en
Scientific article
English

Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections

Published inThe Journal of infectious diseases, vol. 155, no. 2, p. 187-191
Publication date1987
Abstract

In a prospective, randomized trial, teicoplanin (at a 400-mg intravenous loading dose followed by 200 mg/day intravenously or intramuscularly) was compared with flucloxacillin (8 g/day) in patients with severe staphylococcal infections. Teicoplanin proved unsatisfactory for the following reasons: failures or relapses were more frequent in the teicoplanin group, and blood levels were difficult to predict and tended to be low 24 hr after the loading dose. Future trials with this agent should use much-higher doses.

Keywords
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents/ therapeutic use
  • Clinical Trials as Topic
  • Cloxacillin/ analogs & derivatives
  • Floxacillin/administration & dosage/ therapeutic use
  • Glycopeptides/administration & dosage/blood/therapeutic use
  • Humans
  • Middle Aged
  • Prospective Studies
  • Random Allocation
  • Staphylococcal Infections/ drug therapy
  • Staphylococcus/drug effects
  • Staphylococcus aureus/drug effects
  • Teicoplanin
Citation (ISO format)
CALAIN, Philippe et al. Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections. In: The Journal of infectious diseases, 1987, vol. 155, n° 2, p. 187–191. doi: 10.1093/infdis/155.2.187
Main files (1)
Article
accessLevelRestricted
Identifiers
ISSN of the journal0022-1899
569views
0downloads

Technical informations

Creation06/21/2010 10:23:27 AM
First validation06/21/2010 10:23:27 AM
Update time03/14/2023 3:42:58 PM
Status update03/14/2023 3:42:57 PM
Last indexation02/12/2024 6:27:41 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack